Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis. Boutiere C, Saunier R, Rico A, Perriguey M, et al. Rev Neurol (Paris) 2026 Jan 16:S0035-3787(26)00001.

Read + Share

Amedeo Smart

Independent Medical Education

Boutiere C, Saunier R, Rico A, Perriguey M, et al. Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis. Rev Neurol (Paris) 2026 Jan 16:S0035-3787(26)00001.
PMID: 41547622